著者: SzücsJ, HorváthC, KollinE, SzathmáriM, HollóI

原題: Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.

著者: OttS M, ChesnutC H

原題: Calcitriol treatment is not effective in postmenopausal osteoporosis.

著者: KuntzD, MarieP, BerhelM, CaulinF

原題: Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.

著者: TakizawaH, IgarashiM, HayashiY, KarubeS, KimuraH

原題: [Comparison of treatments in senile osteoporosis: follow up for 12 months (author's transl)].

著者: LibermanU A, WeissS R, BröllJ, MinneH W, QuanH, BellN H, Rodriguez-PortalesJ, DownsR W, DequekerJ, FavusM

原題: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

著者: HaslingC, CharlesP, JensenF T, MosekildeL

原題: A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.

著者: HassagerC, ChristiansenC

原題: Epidemiology, biochemistry and some results with treatment of postmenopausal osteoporosis.

著者: BuffoL, RossiniM, BuoncristianoA, GirardelloS, ZamberlanN, DianiF, AdamiS

原題: [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].

著者:

原題: Bone density measurement--a systematic review. A report from SBU, the Swedish Council on Technology Assessment in Health Care.

著者: LindsayR, NievesJ, FormicaC, HennemanE, WoelfertL, ShenV, DempsterD, CosmanF

原題: Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.

著者: EnsrudK E, BlackD M, PalermoL, BauerD C, Barrett-ConnorE, QuandtS A, ThompsonD E, KarpfD B

原題: Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.

著者: SaagK G, EmkeyR, SchnitzerT J, BrownJ P, HawkinsF, GoemaereS, ThamsborgG, LibermanU A, DelmasP D, MaliceM P, CzachurM, DaifotisA G

原題: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

著者: ShiotaE

原題: Evaluation of the drug therapy for established osteoporosis by dual-energy x-ray absorptiometry.

著者: HarrisS T, WattsN B, GenantH K, McKeeverC D, HangartnerT, KellerM, ChesnutC H, BrownJ, EriksenE F, HoseyniM S, AxelrodD W, MillerP D

原題: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

著者: BlankR D, BockmanR S

原題: A review of clinical trials of therapies for osteoporosis using fracture as an end point.

著者: HomikJ, CranneyA, SheaB, TugwellP, WellsG, AdachiR, Suarez-AlmazorM

原題: Bisphosphonates for steroid induced osteoporosis.

著者: CampusanoC, LópezJ M, CampinoC, CárdenasI, RojasA

原題: [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].

著者: RolnickS J, KopherR, JacksonJ, FischerL R, CompoR

原題: What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting?

著者: DrakeW M, KendlerD L, BrownJ P

原題: Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.

著者: SosaM, HernándezD, SegarraM C, GómezA, de la PeñaE, BetancorP

原題: Effect of two forms of alendronate administration upon bone mass after two years of treatment.

著者: BonaiutiD, SheaB, IovineR, NegriniS, RobinsonV, KemperH C, WellsG, TugwellP, CranneyA

原題: Exercise for preventing and treating osteoporosis in postmenopausal women.

著者: GreenspanSusan L, EmkeyRonald D, BoneHenry G, WeissStuart R, BellNorman H, DownsRobert W, McKeeverClark, MillerSam S, DavidsonMichael, BologneseMichael A, MulloyAnthony L, HeydenNorman, WuMei, KaurAmarjot, LombardiAntonio

原題: Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

著者: HäuselmannH J, RizzoliR

原題: A comprehensive review of treatments for postmenopausal osteoporosis.

著者: GreenspanSusan L, ResnickNeil M, ParkerRobert A

原題: Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.

著者: PrestwoodKaren M, KennyAnne M, KleppingerAlison, KulldorffMartin

原題: Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.

著者: CranneyA, WaldeggerL, ZytarukN, SheaB, WeaverB, PapaioannouA, RobinsonV, WellsG, TugwellP, AdachiJ D, GuyattG

原題: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

著者:

原題: [Osteoporosis--prevention, diagnosis and treatment. A systematic literature review. SBU conclusions and summary].

著者: LewieckiE Michael

原題: Nonresponders to osteoporosis therapy.

著者: Elliot-GibsonV, BogochE R, JamalS A, BeatonD E

原題: Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

著者: MuscosoE, PuglisiN, MamazzaC, Lo GiudiceF, TestaiM, AbbateS, SantangeloA, PanebiancoP, MaugeriD

原題: Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.

著者: MorabitoNancy, GaudioAgostino, LascoAntonino, CatalanoAntonino, AtteritanoMarco, TrifilettiAldo, AnastasiGiuseppina, MelloniDarwin, FrisinaNicola

原題: Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.

著者: StevensonM, JonesM Lloyd, De NigrisE, BrewerN, DavisS, OakleyJ

原題: A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

著者: HoAndrew Y Y, KungAnnie W C

原題: Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women.

著者: SmallRalph E

原題: Uses and limitations of bone mineral density measurements in the management of osteoporosis.

著者: FeldsteinAdrianne, ElmerPatricia J, SmithDavid H, HersonMichael, OrwollEric, ChenChuhe, AickinMikel, SwainMartha C

原題: Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial.

著者: JeffcoatMarjorie K

原題: Safety of oral bisphosphonates: controlled studies on alveolar bone.

著者: O'DonnellS, CranneyA, WellsG A, AdachiJ D, ReginsterJ Y

原題: Strontium ranelate for preventing and treating postmenopausal osteoporosis.

著者: BlackDennis M, SchwartzAnn V, EnsrudKristine E, CauleyJane A, LevisSilvina, QuandtSara A, SatterfieldSuzanne, WallaceRobert B, BauerDouglas C, PalermoLisa, WehrenLois E, LombardiAntonio, SantoraArthur C, CummingsSteven R,

原題: Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

著者: DelmasPierre D, VrijensBernard, EastellRichard, RouxChristian, PolsHuibert A P, RingeJohann D, GrauerAndreas, CahallDavid, WattsNelson B,

原題: Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.

著者: CranneyA, AdachiJ D, GuyattG, PapaioannouA, RobinsonV A, SheaB J, TugwellP, WaldeggerL M, WeaverB, WellsG, ZytarukN

原題: WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

著者: BarlowD H

原題: Osteoporosis guidelines.

著者: AdamiS, San MartinJ, Muñoz-TorresM, EconsM J, XieL, DalskyG P, McClungM, FelsenbergD, BrownJ P, BrandiM L, SiposA

原題: Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.

著者: SaagKenneth G, ShaneElizabeth, BoonenSteven, MarínFernando, DonleyDavid W, TaylorKathleen A, DalskyGail P, MarcusRobert

原題: Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

著者: GuvenZeynep, Karadag-SaygiEvrim, Unlu-OzkanFeyza, AkyuzGulseren

原題: The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.

著者: VälimäkiMatti J, Farrerons-MinguellaJordi, HalseJohan, KrögerHeikki, MaroniMarilyn, MulderHenk, Muñoz-TorresManuel, SääfMaria, Snorre ØfjordErik

原題: Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

著者: MacLeanCatherine, NewberrySydne, MaglioneMargaret, McMahonMaureen, RanganathVeena, SuttorpMarika, MojicaWalter, TimmerMartha, AlexanderAlicia, McNamaraMelissa, DesaiSheetal B, ZhouAnnie, ChenSusan, CarterJason, TringaleCarlo, ValentineDi, JohnsenBreanne, GrossmanJennifer

原題: Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

著者: NielsenDorthe, RygJesper, NissenNis, NielsenWinnie, KnoldBerit, BrixenKim

原題: Multidisciplinary patient education in groups increases knowledge on osteoporosis: a randomized controlled trial.

著者: IizukaTakahiro, MatsukawaMitsuhiro

原題: Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.

著者: BrandãoCristina Mariano Ruas, LimaMarina Guimarães, SilvaAnderson Lourenço da, SilvaGraziele Dias, GuerraAugusto Afonso, AcúrcioFrancisco de Assis

原題: Treatment of postmenopausal osteoporosis in women: a systematic review.

著者: MikiRoberto A, OetgenMatthew E, KirkJessica, InsognaKarl L, LindskogDieter M

原題: Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial.

著者: BrancoJaime C, FelicíssimoPaulo, MonteiroJacinto

原題: [Epidemiology of hip fractures and its social and economic impact. A revision of severe osteoporosis current standard of care].

著者: StránskýM, RyšaváL

原題: Nutrition as prevention and treatment of osteoporosis.

著者: PepponeL J, HeblS, PurnellJ Q, ReidM E, RosierR N, MustianK M, PaleshO G, HustonA J, LingM N, MorrowG R

原題: The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review.

著者: BodyJ-J, BergmannP, BoonenS, BoutsenY, DevogelaerJ-P, GoemaereS, KaufmanJ-M, RozenbergS, ReginsterJ-Y

原題: Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.

著者: HeaneyRobert P, ReckerRobert R, WatsonPatrice, LappeJoan M

原題: Phosphate and carbonate salts of calcium support robust bone building in osteoporosis.

著者: WhiteH J, BettiolS S, PereraR, RobertsN W, JavaidM K, FarmerAndrew J

原題: A systematic review assessing the effectiveness of interventions to improve persistence with anti-resorptive therapy in women at high risk of clinical fracture.

著者: GallacherS J, DixonT

原題: Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.